Affiliation:
1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030
Abstract
Ligands for the nuclear receptor superfamily control many aspects of biology, including development, reproduction, and homeostasis, through regulation of the transcriptional activity of their cognate receptors. Selective receptor modulators (SRMs) are receptor ligands that exhibit agonistic or antagonistic biocharacter in a cell- and tissue context-dependent manner. The prototypical SRM is tamoxifen, which as a selective estrogen receptor modulator, can activate or inhibit estrogen receptor action. SRM-induced alterations in the conformation of the ligand-binding domains of nuclear receptors influence their abilities to interact with other proteins, such as coactivators and corepressors. It has been postulated, therefore, that the relative balance of coactivator and corepressor expression within a given target cell determines the relative agonist vs. antagonist activity of SRMs. However, recent evidence reveals that the cellular environment also plays a critical role in determining SRM biocharacter. Cellular signaling influences the activity and subcellular localization of coactivators and corepressors as well as nuclear receptors, and this contributes to gene-, cell-, and tissue-specific responses to SRM ligands. Increased understanding of the effect of cellular environment on nuclear receptors and their coregulators has the potential to open the field of SRM discovery and research to many members of the nuclear receptor superfamily.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference337 articles.
1. Molecular mechanisms of action of steroid/thyroid receptor superfamily members.;Tsai;Annu Rev Biochem,1994
2. The coregulator exchange in transcriptional functions of nuclear receptors.;Glass;Genes Dev,2000
3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.;Rossouw;JAMA,2002
4. Species-specific pharmacology of antiestrogens: role of metabolism.;Jordan;Fed Proc,1987
5. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.;Gottardis;Cancer Res,1988
Cited by
806 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献